Robert Alexander Ingram - 28 May 2021 Form 4 Insider Report for BIOCRYST PHARMACEUTICALS INC (BCRX)

Role
Director
Signature
/s/ Alane P. Barnes, by power of attorney
Issuer symbol
BCRX
Transactions as of
28 May 2021
Transactions value $
$18,735
Form type
4
Filing time
01 Jun 2021, 16:27:39
Previous filing
27 May 2021
Next filing
22 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCRX Common Stock Award $18.7K +1.19K +1.58% $15.77 76.2K 28 May 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Common Stock issued to the reporting person in lieu of quarterly cash Board Member retainer of $18,750.